Menopausal symptoms and fertility concerns in premenopausal breast cancer survivors: A comparison to age- and gravidity-matched controls

Menopause

Volumn 18, Issue 1, 2011, Pages 105-108

  Ruddy, Kathryn J ^a   Gelber, Shari ^a   Ginsburg, Elizabeth S ^b   Schapira, Lidia ^c   Abusief, Mary E ^b   Meyer, Meghan E ^a   Partridge, Ann H ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Anxiety; Hot flashes; Infertility; Menopause; Premature

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; TAMOXIFEN; TAXANE DERIVATIVE;

ADULT; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVOR; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; FEMALE; FEMALE FERTILITY; FEMALE INFERTILITY; HUMAN; MASTECTOMY; MENOPAUSAL SYNDROME; OVARIAN RESERVE; PREGNANCY; PREMENOPAUSE; SCORING SYSTEM;

ADULT; ANTINEOPLASTIC AGENTS, HORMONAL; ANXIETY; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; FERTILITY; HUMANS; OVARY; PREMENOPAUSE; QUESTIONNAIRES; STATISTICS, NONPARAMETRIC; TAMOXIFEN;

EID: 78651400174     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e3181ef39f8     Document Type: Article

References (14)

1. Schover LR. Premature ovarian failure and its consequences: vasomotor symptoms, sexuality, and fertility. J Clin Oncol 2008;26:753-758.
2. Nystedt M, Berglund G, Bolund C, Brandberg Y, Fornander T, Rutqvist LE. Randomized trial of adjuvant tamoxifen and/or goserelin in premenopausal breast cancerVself-rated physiological effects and symptoms. Acta Oncol 2000;39:959-968.
3. Loprinzi CL, Wolf SL, Barton DL, Laack NN. Symptom management in premenopausal patients with breast cancer. Lancet Oncol 2008;9:993-1001.
4. Wenzel LB, Fairclough DL, Brady MJ, et al. Age-related differences in the quality of life of breast carcinoma patients after treatment. Cancer 1999;86:1768-1774.
5. Partridge AH, Ruddy KJ. Fertility and adjuvant treatment in young women with breast cancer. Breast 2007;16:S175-S181.
6. Partridge AH, Gelber S, Peppercorn J, et al. Web-based survey of fertility issues in young women with breast cancer. J Clin Oncol 2004;22: 4174-4183.
7. Dunn J, Steginga SK. Young women's experience of breast cancer: defining young and identifying concerns. Psychooncology 2000;9:137-146.
8. Schover LR. Sexuality and body image in younger women with breast cancer. J Natl Cancer Inst Monogr 1994;16:177-182.
9. Partridge AH, Ruddy KJ, Gelber S, et al. Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer. Fertil Steril 2010;94:638-644.
10. Ganz PA, Day R, Ware JE, Redmond C, Fisher B. Base-line quality-of-life assessment in the National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial. J Natl Cancer Inst 1995;87:1372-1382.
11. Ganz PA, Rowland JH, Desmond K, Meyerowitz BE, Wyatt GE. Life after breast cancer: understanding women's health-related quality of life and sexual functioning. J Clin Oncol 1998;16:501-514.
12. Leining MG, Gelber S, Rosenberg R, Przypyszny M, Winer EP, Partridge AH. Menopausal-type symptoms in young breast cancer survivors. Ann Oncol 2006;17:1777-1782.
13. Day R, Ganz PA, Costantino JP, Cronin WM, Wickerham DL, Fisher B. Health-related quality of life and tamoxifen in breast cancer prevention: a report from the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Clin Oncol 1999;17:2659-2669.
14. Rosen A. Third-party reproduction and adoption in cancer patients. J Natl Cancer Inst Monogr 2005;34:91-93.